Abstract
Recombinant isopenicillin N synthase fromStreptomyces clavuligerus was produced in the form of inactive inclusion bodies inEscherichia coli. These inclusion bodies were solubilized by treatment with 5 M urea under reducing conditions. Optimization of refolding conditions to recover active isopenicillin N synthase indicated that a dialysis procedure carried out at a protein concentration of about 1.0 mg ml−1 gave maximal recovery of active isopenicillin N synthase. Solubilized isopenicillin N synthase of more than 95% purity was obtained by passing this material through a DEAE-Trisacryl ion exchange column. Expression studies conducted at different temperatures indicated that isopenicillin N synthase was produced predominantly in a soluble, active form when expression was conducted at 20°C, and accounted for about 20% of the total soluble protein. This high-level production facilitated the purification of soluble isopenicillin N synthase to near homogeneity in four steps. Characterization of the purified soluble and solubilized isopenicillin N synthase revealed that they are very similar.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldwin JE, SJ Killin, AJ Pratt, JD Sutherland, NJ Turner, MJC Crabbe, EP Abraham and AC Willis. 1987. Purification and characterization of cloned isopenicillin N synthetase. J Antibiot 40: 652–659.
Baldwin JE, JM Blackburn, JD Sutherland and MC Wright. 1991. High-level soluble expression of isopenicillin N synthase isozymes inE. coli. Tetrahedron 47: 5991–6002.
Blackshear PJ. 1984. Systems for polyacrylamide gel electrophoresis. Methods Enzymol 104: 237–255.
Bradford M. 1976. A rapid, sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72: 248–254.
Chalmers JJ, E Kim, JN Telford, EY Wong, WC Tacon, ML Shuler and DB Wilson. 1990. Effects of temperature onEscherichia coli over-producing β-lactamase or human growth factor. Appl Environ Microbiol 56: 104–111.
Durairaj M, JL Doran and SE Jensen. 1992. High-level expression of theStreptomyces clavuligerus isopenicillin N synthase gene inEscherichia coli. Appl Environ Microbiol 58: 4038–4041.
Haase-Pettingell CA and J King. 1988. Formation of aggregates from a thermolabilein vivo folding intermediate in P22 tailspike maturation: a model for inclusion body formation. J Biol Chem 263: 4977–4983.
Jensen SE, DWS Westlake and S Wolfe. 1982. Cyclization of δ-(l-α-aminoadipyl)-l-cysteinyl-d-valine to penicillins by cell-free extracts ofStreptomyces clavuligerus. J Antibiot 35: 483–490.
Jensen SE, DWS Westlake and S Wolfe. 1982. High performance liquid chromatographic assay of cyclization activity in cell-free systems fromStreptomyces clavuligerus. J Antibiot 35: 1026–1032.
Jensen SE, BK Leskiw, LC Vining, Y Aharonowitz, DWS Westlake and S Wolfe. 1986. Purification of isopenicillin N synthetase fromStreptomyces clavuligerus. Can J Microbiol 32: 953–958.
Jensen SE and AL Demain. 1995. Beta-lactams. In: Genetics and Biochemistry of Antibiotic Production (Vining LC and C Stuttard, eds), pp 239–268, Butterworth Heinemann, Boston.
Kane JF and DL Hartley. 1988. Formation of recombinant protein inclusion bodies inEscherichia coli. Trends Biotechnol 6: 95–101.
Kriauciunas A, CA Frolik, TC Hassell, PL Skatrud, MG Johnson, NL Holbrook and VJ Chen. 1991. The functional role of cysteines in isopenicillin N synthase-correlation of cysteine reactivities toward sulfhydryl reagents with kinetic properties of cysteine mutants. J Biol Chem 266: 11779–11788.
Kuwajima K, M Mitani and S Sugai. 1989. Characterization of the critical state in protein folding: effects of guanidine hydrochloride and specific Ca2+ binding on the folding kinetics of α-lactalbumin. J Mol Biol 206: 547–561.
Landman O, D Shiffman, Y Av-Gay, Y Aharonowitz and G Cohen. 1991. High level expression inEscherichia coli of isopenicillin N synthase genes fromFlavobacterium andStreptomyces, and recovery of active enzyme from inclusion bodies. FEMS Microbiol Lett 84: 239–244.
Luisi BF and K Nagai. 1986. Crystallographic analysis of mutant human haemoglobins made inEscherichia coli. Nature 320: 555–556.
Orville AM, VJ Chen, A Kriauciunas, MR Harpel, BG Fox, E Munck and JD Lipscomb. 1992. Thiolate ligation of the active site Fe2+ of isopenicillin N synthase derives from substrate rather than endogenous cysteine: spectroscopic studies of site-specific cys-ser mutated enzymes. Biochemistry 31: 4602–4612.
Piatak M, JA Lane, W Laird, MJ Bjorn, A Wang and M Williams. 1988. Expression of soluble and fully functional ricin A chain inEscherichia coli is temperature-sensitive. J Biol Chem 263: 4837–4843.
Samson SM, R Belagaje, DT Blankenship, JL Chapman, D Perry, PL Skatrud, RM Van Frank, EP Abraham, JE Baldwin, SW Queener and TD Ingolia. 1985. Isolation, sequence determination and expression inE. coli of the isopenicillin N synthetase gene fromCephalosporium acremonium.
Samson SM, JL Chapman, R Belagajie, SW Queener and TD Ingolia. 1987. Analysis of the role of cysteine residues in isopenicillin N synthase activity by site-directed mutagenesis. Proc Natl Acad Sci USA 84: 5705–5709.
Schein CH. 1989. Production of soluble recombinant proteins in bacteria. Bio/Technology 7: 1141–1149.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Durairaj, M., Jensen, S.E. Purification and characterization of recombinantStreptomyces clavuligerus isopenicillin N synthase produced inEscherichia coli . Journal of Industrial Microbiology 16, 197–203 (1996). https://doi.org/10.1007/BF01570004
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01570004